Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Anticancer therapies face challenges including drug resistance and toxic side effects.
• Novel therapeutic strategies are needed to overcome limitations of current treatments.
• Pharmaceutical drugs remain a cost-effective first-line treatment option for cancer patients.

Purpose of the Study:

• To review the potential of cationic antimicrobial peptides (AMPs) as anticancer agents.
• To explore the mechanisms of action of cationic AMPs in cancer treatment.
• To highlight AMPs as selective and resistance-refractory therapeutic options.

Main Methods:

• Review of existing literature on AMPs and their anticancer properties.
• Analysis of the electrostatic interactions between cationic AMPs and cell membranes.
• Focus on the specific targeting of cancer cells based on surface charge differences.

Main Results:

• Cationic AMPs exhibit broad-spectrum activity, similar to their antibacterial effects.
• Increased phosphatidylserine on cancer cell surfaces facilitates selective binding of cationic AMPs.
• AMPs demonstrate potential for selective cancer cell killing with reduced toxicity.

Conclusions:

• Cationic AMPs represent a promising class of novel anticancer drugs.
• Their unique mechanism of action offers a strategy to overcome current resistance mechanisms.
• Further research into AMPs could lead to more effective and safer cancer therapies.